应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
ZTS Zoetis Inc.
盘后交易 10-23 16:53:52 EDT
81.03
-0.97
-1.18%
盘后
81.14
+0.11
+0.14%
16:45 EDT
最高
81.86
最低
80.60
成交量
250.10万
今开
81.14
昨收
82.00
日振幅
1.54%
总市值
334.84亿
流通市值
333.84亿
总股本
4.13亿
成交额
2.03亿
换手率
0.61%
流通股本
4.12亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读｜Zoetis Inc.盘中上涨5.11%，季度股息维持不变
行情直击 · 10-16
异动解读｜Zoetis Inc.盘中上涨5.11%，季度股息维持不变
美国FDA紧急授权：Simparica Trio用于治疗犬类新世界螺旋蝇感染
美股速递 · 08-14
美国FDA紧急授权：Simparica Trio用于治疗犬类新世界螺旋蝇感染
知名投资人迈克尔・伯里更新组合 加大科技板块空头押注
金吾财讯 · 08-13
知名投资人迈克尔・伯里更新组合 加大科技板块空头押注
异动解读｜硕腾盘中下跌5.22%，大幅下调全年指引后反弹行情迅速回吐
行情直击 · 08-08
异动解读｜硕腾盘中下跌5.22%，大幅下调全年指引后反弹行情迅速回吐
异动解读｜硕腾盘中上涨6.99%，Q2每股收益小幅超预期触发超跌修复
行情直击 · 08-06
异动解读｜硕腾盘中上涨6.99%，Q2每股收益小幅超预期触发超跌修复
硕腾高管：定价投资属“点状”与“限期”操作，并非永久性结构变革——电话会议纪要
美股速递 · 08-06
硕腾高管：定价投资属“点状”与“限期”操作，并非永久性结构变革——电话会议纪要
Zoetis高管电话会议透露：将采取激进策略，通过回扣与宠物主销售点计划捍卫市场份额
美股速递 · 08-06
Zoetis高管电话会议透露：将采取激进策略，通过回扣与宠物主销售点计划捍卫市场份额
Zoetis高管表示公司正采用回扣及其他定向投资策略，而非直接下调标价——电话会议披露
美股速递 · 08-06
Zoetis高管表示公司正采用回扣及其他定向投资策略，而非直接下调标价——电话会议披露
异动解读 | 硕腾盘前大涨5.96%，Q2每股收益小幅超预期触发超跌修复
异动解读 · 08-06
异动解读 | 硕腾盘前大涨5.96%，Q2每股收益小幅超预期触发超跌修复
异动解读｜硕腾盘前上涨5.65%，Q2每股收益小幅超预期触发超跌修复
行情直击 · 08-06
异动解读｜硕腾盘前上涨5.65%，Q2每股收益小幅超预期触发超跌修复
异动解读 | Zoetis盘前大跌5.50%，因下调年度业绩预期
异动解读 · 08-06
异动解读 | Zoetis盘前大跌5.50%，因下调年度业绩预期
“大空头”Burry继续押注科技股回调：增持英伟达PUT，继续做空半导体
老虎资讯综合 · 07-31
“大空头”Burry继续押注科技股回调：增持英伟达PUT，继续做空半导体
财报前瞻｜Zoetis Inc.本季度营收预计增3.87%，机构观点偏谨慎
财报Agent · 07-30
财报前瞻｜Zoetis Inc.本季度营收预计增3.87%，机构观点偏谨慎
硕腾(ZTS)长效猫关节炎单抗药物Portela登陆欧盟与加拿大市场
金吾财讯 · 07-22
硕腾(ZTS)长效猫关节炎单抗药物Portela登陆欧盟与加拿大市场
澳大利亚ACCC裁定：Zoetis收购纽尔真检测需进入第二阶段审查
投资观察 · 07-17
澳大利亚ACCC裁定：Zoetis收购纽尔真检测需进入第二阶段审查
ACCC评估Zoetis获取澳洲牛群基因数据对市场竞争的影响
美股速递 · 07-17
ACCC评估Zoetis获取澳洲牛群基因数据对市场竞争的影响
硕腾(ZTS)家禽二联载体疫苗Poulvac® Procerta®HVT-ND获欧盟上市许可
金吾财讯 · 07-07
硕腾(ZTS)家禽二联载体疫苗Poulvac® Procerta®HVT-ND获欧盟上市许可
异动解读｜硕腾盘中上涨5.07%，报81.575美元
行情直击 · 06-04
异动解读｜硕腾盘中上涨5.07%，报81.575美元
硕腾将出席两场投资者会议并参与炉边谈话
环球市场播报 · 05-21
硕腾将出席两场投资者会议并参与炉边谈话
美国食品药品监督管理局授予Dectomax/Dectomax-CA1（多拉菌素注射液）紧急使用授权
美股速递 · 05-19
美国食品药品监督管理局授予Dectomax/Dectomax-CA1（多拉菌素注射液）紧急使用授权
加载更多
公司概况
公司名称：
Zoetis Inc.
所属市场：
NYSE
上市日期：
--
主营业务：
硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。
发行价格：
--
{"stockData":{"symbol":"ZTS","market":"US","secType":"STK","nameCN":"Zoetis Inc.","latestPrice":81.03,"timestamp":1792785600000,"preClose":82,"halted":0,"volume":2501042,"hourTrading":{"tag":"盘后","latestPrice":81.14,"preClose":81.03,"latestTime":"16:45 EDT","volume":135002,"amount":10939019.00714,"timestamp":1792788300543,"change":0.11,"changeRate":0.001358,"amplitude":0.014192},"delay":0,"changeRate":-0.011829268292682913,"floatShares":412000000,"shares":413223600,"eps":6.106906,"marketStatus":"盘后交易","change":-0.97,"latestTime":"10-23 16:53:52 EDT","open":81.14,"high":81.86,"low":80.6001,"amount":202630471.19364002,"amplitude":0.015365,"askPrice":81.35,"askSize":20000,"bidPrice":80.07,"bidSize":5,"shortable":3,"etf":0,"ttmEps":6.106906,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792800000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1359694800000,"exchange":"NYSE","adjPreClose":82,"dividendRate":0.025423,"preHourTrading":{"tag":"盘前","latestPrice":81.62,"preClose":82,"latestTime":"09:29 EDT","volume":8927,"amount":728379.46122,"timestamp":1792762199999,"change":-0.38,"changeRate":-0.004634,"amplitude":0.011341},"postHourTrading":{"tag":"盘后","latestPrice":81.14,"preClose":81.03,"latestTime":"16:45 EDT","volume":135002,"amount":10939019.00714,"timestamp":1792788300543,"change":0.11,"changeRate":0.001358,"amplitude":0.014192},"volumeRatio":0.617736,"impliedVol":0.4901,"impliedVolPercentile":0.9044},"requestUrl":"/m/hq/s/ZTS","defaultTab":"news","newsList":[{"id":"1107560022","title":"异动解读｜Zoetis Inc.盘中上涨5.11%，季度股息维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1107560022","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107560022?lang=zh_cn&edition=full","pubTime":"2026-10-16 02:37","pubTimestamp":1792089420,"startTime":"0","endTime":"0","summary":"10月16日，Zoetis Inc.盘中上涨5.11%，报79.14美元/股，成交额1.95亿美元。消息面上，公司日前宣布将季度股息维持在每股0.53美元，股权登记日为10月30日，派息日为12月1日。该消息显示公司延续稳定股东回报政策。此外，公司上次于8月初披露季度每股收益为1.87美元，下一次财报将于11月5日公布，市场预期每股收益为1.51美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"硕腾盘中强势上涨，股息维持提振信心","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115134429","title":"美国FDA紧急授权：Simparica Trio用于治疗犬类新世界螺旋蝇感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1115134429","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115134429?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:29","pubTimestamp":1786642153,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已针对Simparica Trio产品发布紧急使用授权，专门用于治疗犬只及幼犬所感染的新世界螺旋蝇。这一决定，无疑为深受该寄生虫困扰的宠物群体带来了及时雨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GB00BDT5M118.USD","LU0345774391.USD","LU2271345857.HKD","LU2089283258.USD","LU0385154629.USD","BK4588","LU1236620750.USD","LU1721429741.USD","LU2023251221.USD","LU0289739699.SGD","BK4007","LU0471298694.HKD","LU0107464264.USD","LU1059921491.USD","LU2028103732.USD","IE00B19Z9505.USD","LU1236620834.HKD","ZTS","LU2089284900.SGD","LU2308191902.HKD","LU0079474960.USD","BK4585","LU0471298777.SGD","LU0158827948.USD","PAWZ","LU1941712264.USD","LU0158827781.USD","LU0058720904.USD","LU0345774631.USD","LU1941712348.USD","LU1721429402.USD","BK4534","LU2111349929.HKD","LU2360106947.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659155981","title":"知名投资人迈克尔・伯里更新组合 加大科技板块空头押注","url":"https://stock-news.laohu8.com/highlight/detail?id=2659155981","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659155981?lang=zh_cn&edition=full","pubTime":"2026-08-13 18:40","pubTimestamp":1786617605,"startTime":"0","endTime":"0","summary":"在加码看空科技赛道的同时，该投资人同步增加部分多头仓位，将MercadoLibre与Zoetis纳入多头持仓。一边增加科技方向空头，一边布局其他板块多头，组合呈现明显的多空对冲特征，持仓变动也反映出其对当前科技板块估值水平的谨慎态度。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/ZmY2NTQyNTc0MzU2NTg=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZmY2NTQyNTc0MzU2NTg=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303770","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237957811.SGD","GB00BDT5M118.USD","WUGI","LU0127658192.USD","SMH","LU0949170772.SGD","LU0130102774.USD","LU1935042488.USD","LU2048586759.USD","LU1823568750.SGD","LU0640476718.USD","LU0861579265.USD","IE00BWXC8680.SGD","SGXZ81514606.USD","BK4588","LU0109392836.USD","LU0157215616.USD","BK4579","LEGR","LU0417517546.SGD","LU0107464264.USD","LU0143863198.USD","LU1551013425.SGD","LU0348723411.USD","LU0329931090.USD","LU0133085943.USD","LU0965509010.AUD","IE00BGV7N243.SGD","NEBX","IE00BLSP4239.USD","LU1267930730.SGD","NBIG","SG9999003800.SGD","LU0820561818.USD","LU0531971165.HKD","NBIZ","LU0158827781.USD","LU0689472784.USD","LU2111349929.HKD","LU1934455277.USD","BK4585","IE00BK4W5M84.HKD","LU2471134523.USD","LU0456842615.SGD","LU1316542783.SGD","LU0985489474.SGD","IE00B0JY6N72.USD","LU1145028129.USD","LU2746668461.USD","MUD","IE00BN8TJ469.HKD","BK4609","SHOC","LU2543165471.USD","LU1035773651.USD","ZTS","OGIG","LU2089284900.SGD","LU1868837722.USD","LU0079474960.USD","IE00BMPRXN33.USD","IE00B0169N27.USD","CHPX","BK4543","LU1868837565.USD","LU0353189763.USD","LU2896262040.SGD","LU1941712264.USD","IETC","BK4538","PSI","LU0552385451.USD","LU0889565833.HKD","SGXZ51526630.SGD","SG9999001424.SGD","LU0433182093.SGD","BK4007","FXL","LU1935043023.USD","IE00BMPRXQ63.HKD","LU1934455863.HKD","IE0004445239.USD","LU0957808578.USD","LU2458330243.SGD","LU1201861249.SGD","IE00BKDWB100.SGD","LU1778281490.HKD","DRMY","LU1059921491.USD","LU0738911758.USD","LU1815336760.USD","LU1037948541.HKD","TDIV","LU0786609619.USD","MUZ","MUU","LU2168564065.EUR","LU2028103732.USD","BK4141","LU0056508442.USD","LU0106959298.USD","SORCLmain","IE00B5949003.HKD","TRFK","LU1721429741.USD","LU0683600562.USD","LU0878866978.SGD","RULE","LU1941712348.USD","LU0289739343.SGD","SGXZ99366536.SGD","LU0642271901.SGD","LU0070302665.USD","BK4527","LU1429558221.USD","IE00B8L5B284.USD","LU1868838027.USD","LU2054465674.USD","LU0289960550.SGD","LU2355687059.USD","LU2360107168.USD","LU2860962120.EUR","WLDR","LU0256863811.USD","IE00BK4W5L77.USD","SG9999011175.SGD","BK4512","LU0868486357.SGD","SOXS","LU0823411888.USD","LU1235294995.USD","IE0034235303.USD","LU2102340556.USD","EMSF","LU1366333091.USD","LU1868836591.USD","LU0050427557.USD","LU0320765489.SGD","LU1046421795.USD","SMU00main","LU0950373646.USD","LU2357627491.SGD","LU2750360997.AUD","LU0058720904.USD","LU1935042991.SGD","LU1989764664.SGD","ORCU","TTXU","SOXX","SOXQ","LU0672654240.SGD","LU1914381329.SGD","LU0648001328.SGD","MULL","BK4554","LU1629891620.HKD","LU0820562030.AUD","KMLI","LU0289739699.SGD","BK4533","LU0210535034.USD","LU0096364046.USD","LU1236620834.HKD","AIFD","LU0345774631.USD","LU2023251221.USD","LU2308191902.HKD","LU1506573853.SGD","LU0289961442.SGD","LU1435385759.SGD","LU0476273544.USD","LU0323591593.USD","LU1989764748.USD","BK4605","MU","LU2279701549.SGD","LU1861220207.SGD","LU0354030438.USD","LU0238689110.USD","LU0274383776.USD","MIC","LU1674673428.USD","BK4077","LU1989772840.SGD","LU2290526834.HKD","LU2213496289.HKD","IE00BMPRXR70.SGD","DISK","LU1852331112.SGD","LU1037948897.HKD","LU1691799644.USD","LU1236620750.USD","LU0345774391.USD","LU2471134796.USD","LU1323610961.USD","MUYY","LU1069347547.HKD","ORCX","LU1868836757.USD","LU2357305700.SGD","ORCS","LU0082616367.USD","LU0175139822.USD","LU1548497426.USD","LU2326559502.SGD","LU1935042215.USD","LU1861220033.SGD","LU2286300806.USD","LU0208291251.USD","IE00BJLML261.HKD","LU2360106780.USD","BK4122","SOXL","LU0889566641.SGD","LU2931357623.SGD","BK4581","LU0792757196.USD","LU0964807845.USD","LU2750360641.GBP","LU0943347566.SGD","LU1674673691.USD","AIQ","ORCL","LU2097829019.USD","LU1551013342.USD","LU0143863784.USD","LU1868836914.USD","LU0965509283.SGD","BK4528","LU1720051108.HKD","LU0329931173.USD","IE00B8HQ1Z84.USD","BK4516","LU1267930813.SGD","LU0158827948.USD","LU0390134368.USD","LU2265009873.SGD","LU2237957902.USD","CGGO","LU0320765059.SGD","LU1642822529.SGD","IE00BBT3K403.USD","ONLN","BAI","IE00B775SV38.USD","BOBP","LU0787776722.HKD","LU2087625088.SGD","LU0061475181.USD","LU2403377893.USD","LU1989772923.USD","LU0154236417.USD","BK4548","LU2168564495.EUR","CHAT","LU0965509101.SGD","FAI","LU0234572021.USD","LU1935043536.SGD","FTXL","LU0198837287.USD","LU0532187761.SGD","LU1489326972.SGD","LU2746668974.SGD","LU2756315664.SGD","LU0511384066.AUD","MELI","BK4566","IE00B7SZLL34.SGD","LU0553294199.USD","NBIL","PTF","LU2236285917.USD","LU1280957306.USD","IE00B1B80R65.USD","LU0385154629.USD","LU2089283258.USD","BK4220","LU2360106947.USD","LU0719512351.SGD","LU0820561909.HKD","LU1868837300.USD","LU0708995401.HKD","LU0545039389.USD","LU0053687314.USD","LU0081259029.USD","LU2756315318.SGD","LU1868837136.USD","BK4097","IE000M9KFDE8.USD","LU0471298777.SGD","IE00B1XK9C88.USD","IE00BLSP4452.SGD","LU0472753341.HKD","LU2471134879.HKD","IE00B19Z3B42.SGD","LU2360107671.USD","LU2211815571.USD","LU2108987350.USD","LU0965508806.USD","LU0314106906.USD","LU0444973449.USD","LU1803068979.SGD","JGRO","LU1934455194.USD","LU1861215975.USD","IGV","LU0431992006.USD","IE00B19Z9505.USD","LU1003077747.HKD","IE00B3S45H60.SGD","IXN","EGGY","LU2089985449.USD","LU0109391861.USD","LU0471298694.HKD","LU1721429402.USD","EFIV","LU0234570918.USD","LU2168564149.EUR","LU1861217088.USD","CHPS","LU2271345857.HKD","LU0859254822.USD","LU0203347892.USD","BK4532","LU2023250330.USD","LU2458330169.SGD","BK4534","BK4575","LU1366192091.USD","IE0009356076.USD","XNTK","LU0444971666.USD","IE00BSNM7G36.USD","LU0210536198.USD","HBMX","LU0823431647.USD","LU0256863902.USD","LU2168563687.JPY","AIS","LU0353189680.USD","LU0661504455.SGD","FTEC","NBIS","LU0068578508.USD","IE0002270589.USD","PAWZ","LU2250418816.HKD","FDTX","USXF","IE00B19Z3581.USD","LU0057025933.USD","LU1804176565.USD","LU2168564222.USD","LU0354030511.USD","LU0980610538.SGD","BK4553","LU0823431563.USD","LU1720051017.SGD","LU2471134952.CNY","VGT","LU0203345920.USD","LU0069063385.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153115244","title":"异动解读｜硕腾盘中下跌5.22%，大幅下调全年指引后反弹行情迅速回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1153115244","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153115244?lang=zh_cn&edition=full","pubTime":"2026-08-08 00:18","pubTimestamp":1786119533,"startTime":"0","endTime":"0","summary":"8月8日，硕腾盘中下跌5.22%，报73.235美元/股，成交额3.98亿美元。消息面上，公司于8月6日发布Q2财报，调整后每股收益1.87美元略超预期，但营收24.68亿美元不及预期的25.02亿美元。更关键的是，公司将全年调整后每股收益指引从6.85至7.00美元大幅下调至6.15至6.25美元，远低于市场预期的6.87美元；全年营收预期降至91.2亿至93.2亿美元，较前值缩减逾6亿美元。此前该股因EPS微幅超预期一度反弹近7%，但指引下调幅度远超市场预期，反弹行情迅速回吐。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176149591","title":"异动解读｜硕腾盘中上涨6.99%，Q2每股收益小幅超预期触发超跌修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1176149591","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176149591?lang=zh_cn&edition=full","pubTime":"2026-08-06 21:43","pubTimestamp":1786023810,"startTime":"0","endTime":"0","summary":"8月6日，硕腾盘中上涨6.99%，报74.335美元/股，成交额1.74亿美元。消息面上，公司发布Q2财报，调整后每股收益1.87美元，略超市场预期的1.86美元，同比增长6.25%；营收24.68亿美元，低于预期的25.02亿美元。同时公司将全年调整后每股收益指引从6.85至7.00美元大幅下调至6.15至6.25美元，全年营收预期降至91.2亿至93.2亿美元，均显著低于市场预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"硕腾盘中上涨6.99%，Q2每股收益小幅超预期触发超跌修复","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194107297","title":"硕腾高管：定价投资属“点状”与“限期”操作，并非永久性结构变革——电话会议纪要","url":"https://stock-news.laohu8.com/highlight/detail?id=1194107297","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194107297?lang=zh_cn&edition=full","pubTime":"2026-08-06 21:18","pubTimestamp":1786022301,"startTime":"0","endTime":"0","summary":"硕腾（Zoetis）高管在电话会议中明确指出，当前的定价投资策略是“有针对性的”且“受时间限制的”，而非永久性的结构性价格调整。这一表态，旨在澄清市场对公司定价策略的误解。会议强调，这些举措本质上属于短期、局部的战术性调整，而不是根本性的、长期的价格体系重塑。这种“点状”与“限期”的操作模式，意味着未来价格可能随市场条件变化而灵活调整，不会形成固化的新定价框架。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1236620750.USD","LU0079474960.USD","LU0058720904.USD","LU2089284900.SGD","LU0158827781.USD","LU2028103732.USD","LU2111349929.HKD","LU0158827948.USD","LU0289739699.SGD","PAWZ","LU2089283258.USD","LU1059921491.USD","LU1941712348.USD","BK4585","LU2360106947.USD","LU1721429402.USD","LU0345774631.USD","LU0107464264.USD","LU2023251221.USD","LU2271345857.HKD","IE00B19Z9505.USD","GB00BDT5M118.USD","BK4007","LU0471298694.HKD","BK4588","LU1721429741.USD","LU0471298777.SGD","ZTS","LU0345774391.USD","LU0385154629.USD","LU1236620834.HKD","LU2308191902.HKD","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194386868","title":"Zoetis高管电话会议透露：将采取激进策略，通过回扣与宠物主销售点计划捍卫市场份额","url":"https://stock-news.laohu8.com/highlight/detail?id=1194386868","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194386868?lang=zh_cn&edition=full","pubTime":"2026-08-06 21:18","pubTimestamp":1786022289,"startTime":"0","endTime":"0","summary":"在近日的一场电话会议中，Zoetis（Zoetis Inc.）高层明确表态：为了守住销量阵地，公司将在回扣政策及宠物主销售点计划上大举发力。通过一系列激进举措，Zoetis期望在竞争激烈的市场中稳固其份额，并进一步巩固与消费者的直接联系。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774391.USD","LU1721429402.USD","LU0058720904.USD","LU2028103732.USD","ZTS","LU1236620834.HKD","BK4585","LU0079474960.USD","LU1941712264.USD","LU2089283258.USD","LU2308191902.HKD","LU2089284900.SGD","LU2271345857.HKD","LU0158827781.USD","LU0158827948.USD","BK4534","LU0107464264.USD","PAWZ","LU1236620750.USD","LU0471298777.SGD","LU0345774631.USD","LU2023251221.USD","LU1059921491.USD","GB00BDT5M118.USD","LU1721429741.USD","IE00B19Z9505.USD","BK4588","LU2111349929.HKD","LU1941712348.USD","LU0385154629.USD","BK4007","LU0471298694.HKD","LU2360106947.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135119715","title":"Zoetis高管表示公司正采用回扣及其他定向投资策略，而非直接下调标价——电话会议披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1135119715","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135119715?lang=zh_cn&edition=full","pubTime":"2026-08-06 21:17","pubTimestamp":1786022229,"startTime":"0","endTime":"0","summary":"Zoetis的一位高管在电话会议中明确表示，公司当前并未考虑削减标价。相反，它正积极运用回扣机制，并配合一系列有针对性的投资举措。这种策略体现了管理层对市场动态的精准把握，他们更倾向于通过灵活的财务工具来维持竞争力，而非简单粗暴地调整价格标签。这一做法，无疑为公司在复杂的经济环境中赢得了更多战略回旋余地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS","BK4007","LU2360106947.USD","LU0471298694.HKD","IE00B19Z9505.USD","LU0385154629.USD","LU0158827781.USD","PAWZ","LU0158827948.USD","LU2089283258.USD","LU2308191902.HKD","LU1721429741.USD","LU0289739699.SGD","LU1236620834.HKD","LU2028103732.USD","BK4588","LU2089284900.SGD","LU0345774391.USD","LU1059921491.USD","LU1721429402.USD","LU2111349929.HKD","LU2023251221.USD","LU2271345857.HKD","BK4585","LU1941712264.USD","LU0058720904.USD","GB00BDT5M118.USD","LU0107464264.USD","LU0471298777.SGD","BK4534","LU1236620750.USD","LU1941712348.USD","LU0345774631.USD","LU0079474960.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128102579","title":"异动解读 | 硕腾盘前大涨5.96%，Q2每股收益小幅超预期触发超跌修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1128102579","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128102579?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:52","pubTimestamp":1786017158,"startTime":"0","endTime":"0","summary":"硕腾(ZTS)今日盘前股价大涨5.96%，引发了市场的广泛关注。消息面上，公司发布了第二季度财报，调整后每股收益为1.87美元，略超市场预期的1.86美元，同比增长6.25%。尽管营收为24.68亿美元，低于预期的25.02亿美元，且公司同步将全年调整后每股收益指引从此前的6.85至7.00美元大幅下调至6.15至6.25美元，全年营收预期也降至91.2亿至93.2亿美元，但该股此前已因第一季度业绩不及预期及首次下调指引累计暴跌超过30%，多家投行连续下调目标价至80至85美元区间，市场已计入较多悲观预期。此次盈利小幅超预期，或成为超跌修复的催化剂，推动股价反弹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177530135","title":"异动解读｜硕腾盘前上涨5.65%，Q2每股收益小幅超预期触发超跌修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1177530135","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177530135?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:51","pubTimestamp":1786017076,"startTime":"0","endTime":"0","summary":"8月6日，硕腾盘前上涨5.65%，报78.2美元/股，成交额2928.27万美元。消息面上，公司发布Q2财报，调整后每股收益1.87美元，略超市场预期的1.86美元，同比增长6.25%；营收24.68亿美元，低于预期的25.02亿美元。但该股此前已因Q1业绩不及预期及首次下调指引累计暴跌超30%，多家投行连续下调目标价至80-85美元区间，市场已计入较多悲观预期，盈利小幅超预期或成为超跌修复催化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"硕腾盘前上涨5.65%，Q2每股收益小幅超预期触发超跌修复","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151036661","title":"异动解读 | Zoetis盘前大跌5.50%，因下调年度业绩预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1151036661","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151036661?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:30","pubTimestamp":1786015821,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc.（ZTS）今日盘前股价大跌5.50%，引发市场广泛关注。消息面上，公司下调了2026年全年业绩指引。Zoetis预计2026年经调整后每股收益（EPS）为6.15至6.25美元，远低于此前预测的6.85至7.00美元；营收预期也从96.8亿至99.6亿美元下调至91.2亿至93.2亿美元，低于分析师平均预期的97.3亿美元。公司首席执行官克里斯汀·佩克表示，第二季度业绩反映出伴侣动物市场面临更大压力，诊所就诊次数减少以及宠物主人对价格的敏感度提高，导致部分产品组合需求下降，并加剧了关键品类的竞争。这一悲观展望直接打击了投资者信心，导致股价盘前重挫。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170879426","title":"“大空头”Burry继续押注科技股回调：增持英伟达PUT，继续做空半导体","url":"https://stock-news.laohu8.com/highlight/detail?id=1170879426","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170879426?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:22","pubTimestamp":1785496939,"startTime":"0","endTime":"0","summary":"《大空头》原型人物Michael Burry并未收手，反而进一步加码做空英伟达、 美光等科技股。7月30日，Michael Burry再次大幅调整投资组合。这次没有减仓或清仓操作，而是全面提升风险敞口：一方面逢低买入 $DraftKings Inc.$、 $Zoetis Inc.$和 $lululemon athletica$；另一方面继续加码长期看跌布局，包括增持$纳指100ETF$和 $英伟达$的长期看跌期权，同时进一步做空 $美光科技$和 $半导体指数ETF-HOLDRs$。但在Burry看来，市场上的股票虽然成千上万，真正值得交易的机会却并不多。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07788","MIC","MSFO","MUZ","SMH","QQQ","MSFY","META","NVII","METU","NVDD","MSFX","NVDB","DKNG","FBY","MUD","DKNX","NVDO","NVDS","NVDA","ANV","MSFT","MSFD","MSFW","FBYY","NVDU","DRAY","07388","NVDQ","LULU","MU","NVD","MSFU","ZTS","MSFL","MULL","FBL","MUYY","NVDG","NVDY","NVDX","DIPS","MUU","METW","METD","NVDW","NVDL","NVYY","DKUP","LULG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1188083297","title":"财报前瞻｜Zoetis Inc.本季度营收预计增3.87%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1188083297","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188083297?lang=zh_cn&edition=full","pubTime":"2026-07-30 09:27","pubTimestamp":1785374831,"startTime":"0","endTime":"0","summary":"Zoetis Inc.将于2026年08月06日美股盘前发布最新季度财报，市场关注营收与盈利修复节奏及费用投放对利润率的影响。市场一致预期本季度Zoetis Inc.营收为25.02亿美元，同比增3.87%，调整后每股收益为1.86美元，同比增14.74%；目前一致预期未覆盖本季度毛利率与净利率/净利润，相关数据暂未形成可比口径。上季度Zoetis Inc.营收22.62亿美元，同比增1.89%；毛利率71.71%；归属于母公司股东的净利润6.01亿美元，净利率26.57%；调整后每股收益1.53美元，同比增3.38%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Zoetis Inc.本季度营收预计增3.87%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653750538","title":"硕腾(ZTS)长效猫关节炎单抗药物Portela登陆欧盟与加拿大市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2653750538","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653750538?lang=zh_cn&edition=full","pubTime":"2026-07-22 20:07","pubTimestamp":1784722053,"startTime":"0","endTime":"0","summary":"全球动物保健龙头硕腾宣布，长效单抗药物 Portela正式在加拿大与欧盟成员国上市。Portela 将与硕腾现有猫关节炎药物 Solensia 形成产品矩阵。同为抗 NGF 单抗，Solensia 需要每月注射，而 Portela 实现三月一针，大幅降低频繁送医、日常喂药难题，适配慢性骨关节炎长期管理需求。本次 Portela 在欧美市场商业化落地，进一步巩固其在宠物疼痛管理赛道的领先地位，满足老龄化宠物群体日益增长的慢病诊疗需求。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NjkwOTdhNzcyN2U0YmYwYmQ0MTU5ZmNlZDZlMGU5OTExMDg1MTQ4NjI3MDM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjkwOTdhNzcyN2U0YmYwYmQ0MTU5ZmNlZDZlMGU5OTExMDg1MTQ4NjI3MDM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302896","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089284900.SGD","LU2111349929.HKD","LU1941712264.USD","LU0345774391.USD","LU2089283258.USD","LU1059921491.USD","FESXmain","BK4585","LU2308191902.HKD","LU0345774631.USD","LU0158827781.USD","ZTS","LU2271345857.HKD","BK4534","LU0289739699.SGD","LU0471298694.HKD","LU0107464264.USD","LU1941712348.USD","LU2360106947.USD","GB00BDT5M118.USD","LU1236620834.HKD","LU2023251221.USD","PAWZ","LU2028103732.USD","EWC","LU0158827948.USD","LU1721429741.USD","BK4588","BK4007","LU0471298777.SGD","LU0385154629.USD","BK4582","IE00B19Z9505.USD","LU1236620750.USD","FSXEmain","LU1721429402.USD","LU0079474960.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132505645","title":"澳大利亚ACCC裁定：Zoetis收购纽尔真检测需进入第二阶段审查","url":"https://stock-news.laohu8.com/highlight/detail?id=1132505645","media":"投资观察","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132505645?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:30","pubTimestamp":1784284245,"startTime":"0","endTime":"0","summary":"澳大利亚竞争与消费者委员会于7月17日宣布，将对Zoetis Inc.收购纽尔真检测旗下基因组学业务的交易进行第二阶段审查。监管机构表示，目前尚未就相关问题达成最终结论，将在下一阶段继续深入评估此项收购案。ACCC在声明中特别指出，委员会正在审慎考量Zoetis通过此次交易获取澳大利亚境内更大量牛群遗传数据可能带来的竞争影响。根据ACCC的安排，针对此项收购的第二阶段审查通知已正式发布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0345774631.USD","LU2089283258.USD","LU1721429402.USD","LU2111349929.HKD","LU1721429741.USD","LU1059921491.USD","PAWZ","LU1941712264.USD","LU2271345857.HKD","LU2023251221.USD","ZTS","LU0385154629.USD","IE00B19Z9505.USD","NEOG","LU2089284900.SGD","LU0158827948.USD","LU0471298777.SGD","BK4534","LU1941712348.USD","LU2360106947.USD","LU0158827781.USD","LU2308191902.HKD","LU0079474960.USD","LU0058720904.USD","BK4198","BK4585","LU0345774391.USD","BK4588","LU0107464264.USD","LU2028103732.USD","LU2211817866.USD","LU1236620834.HKD","GB00BDT5M118.USD","LU1236620750.USD","LU0471298694.HKD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104446115","title":"ACCC评估Zoetis获取澳洲牛群基因数据对市场竞争的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1104446115","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104446115?lang=zh_cn&edition=full","pubTime":"2026-07-17 14:16","pubTimestamp":1784268980,"startTime":"0","endTime":"0","summary":"澳大利亚竞争与消费者委员会（ACCC）正在评估一项交易可能带来的竞争影响。该交易涉及Zoetis Inc.获得澳大利亚境内更大量牛群遗传数据的访问权限。监管机构正审视此举是否会对市场公平竞争构成影响，尤其是在动物健康领域的数据获取方面。分析重点在于数据量的增加可能如何改变市场格局，以及这是否会赋予Zoetis相对于其他市场参与者潜在的不公平优势。这一审查反映了全球监管机构对数据密集型交易竞争效应的日益关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1941712348.USD","LU0345774631.USD","LU1059921491.USD","LU0289739699.SGD","LU1941712264.USD","LU2308191902.HKD","BK4534","BK4007","LU0107464264.USD","BK4198","BK4585","LU2089284900.SGD","NEOG","LU0471298777.SGD","PAWZ","LU2111349929.HKD","LU2028103732.USD","LU2360106947.USD","LU0385154629.USD","LU0079474960.USD","LU2271345857.HKD","IE00B19Z9505.USD","LU0345774391.USD","LU1236620834.HKD","LU0158827948.USD","GB00BDT5M118.USD","LU1236620750.USD","LU2023251221.USD","LU0058720904.USD","LU0471298694.HKD","LU1721429402.USD","LU1721429741.USD","LU2089283258.USD","ZTS","LU2211817866.USD","BK4588","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649982576","title":"硕腾(ZTS)家禽二联载体疫苗Poulvac® Procerta®HVT-ND获欧盟上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2649982576","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649982576?lang=zh_cn&edition=full","pubTime":"2026-07-07 19:41","pubTimestamp":1783424490,"startTime":"0","endTime":"0","summary":"产品管线层面，该款疫苗是硕腾 Procerta 系列第三款获欧盟认证的 HVT 载体疫苗，此前已有预防传染性法氏囊病 + 马立克氏病、三病联合防护两款产品上市。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302280","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774391.USD","IE00B19Z9505.USD","LU0471298777.SGD","LU1236620834.HKD","BK4178","ZTS","LU2028103732.USD","LU1721429741.USD","LU0289739699.SGD","LU0385154629.USD","LU0158827781.USD","GB00BDT5M118.USD","LU2360106947.USD","BK4534","LU2089283258.USD","LU0471298694.HKD","LU2023251221.USD","BK4585","LU1721429402.USD","LU1236620750.USD","LU2089284900.SGD","LU0107464264.USD","HVT","LU1059921491.USD","LU2271345857.HKD","LU0345774631.USD","IPOS","LU1941712348.USD","LU2111349929.HKD","FSXEmain","LU0158827948.USD","159646","LU0079474960.USD","BK4588","BK4007","LU1941712264.USD","LU2308191902.HKD","PAWZ","LU0058720904.USD","FESXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134049005","title":"异动解读｜硕腾盘中上涨5.07%，报81.575美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134049005","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134049005?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:57","pubTimestamp":1780585060,"startTime":"0","endTime":"0","summary":"6月4日，硕腾盘中上涨5.07%，报81.575美元/股，成交额1.69亿美元。硕腾所在的制药行业中，整体表现强势，个股中，诺和诺德涨5.33%，礼来涨5.13%，默沙东涨3.53%，强生涨1.91%，辉瑞涨1.81%。硕腾公司是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637332288","title":"硕腾将出席两场投资者会议并参与炉边谈话","url":"https://stock-news.laohu8.com/highlight/detail?id=2637332288","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637332288?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:41","pubTimestamp":1779374464,"startTime":"0","endTime":"0","summary":"动物保健行业公司硕腾于当地时间5月20日宣布，公司代表将出席本月末及下月初的两场投资者会议，并进行炉边谈话。 根据公司公告，硕腾将出席美东时间5月28日下午3时举行的Stifel 2026年Jaws & Paws会议，以及美东时间6月2日下午1时20分举行的William Blair第46届年度成长股会议。两场会议均设炉边谈话环节，投资者可通过硕腾官网投资者关系页面观看直播，回放也将在活动结束后提供。 硕腾近期经营环境面临挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-21/doc-inhysnxi8161733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LU2089283258.USD","LU1941712348.USD","BK4534","LU1721429741.USD","LU0345774391.USD","BK4007","LU1236620750.USD","LU1721429402.USD","LU0385154629.USD","LU0158827781.USD","LU2023251221.USD","LU1236620834.HKD","LU0471298777.SGD","LU0058720904.USD","LU2308191902.HKD","LU2089284900.SGD","LU0345774631.USD","GB00BDT5M118.USD","LU2360106947.USD","ZTS","IE00B19Z9505.USD","LU1059921491.USD","LU0471298694.HKD","LU0289739699.SGD","BK4588","BK4585","LU0079474960.USD","LU0107464264.USD","LU1941712264.USD","LU2111349929.HKD","LU0158827948.USD","LU2028103732.USD","LU2271345857.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110203987","title":"美国食品药品监督管理局授予Dectomax/Dectomax-CA1（多拉菌素注射液）紧急使用授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1110203987","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110203987?lang=zh_cn&edition=full","pubTime":"2026-05-19 23:38","pubTimestamp":1779205101,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式授予Dectomax及Dectomax-CA1（多拉菌素注射液）这一可注射溶液的紧急使用授权（EUA）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2308191902.HKD","LU0058720904.USD","LU0158827948.USD","LU0079474960.USD","LU2271345857.HKD","LU1721429402.USD","LU0385154629.USD","LU2360106947.USD","LU0345774391.USD","BK4534","LU2023251221.USD","LU0471298694.HKD","LU1236620750.USD","LU0471298777.SGD","IE00B19Z9505.USD","LU1236620834.HKD","LU1721429741.USD","LU1941712264.USD","LU1941712348.USD","LU2028103732.USD","BK4588","LU2089283258.USD","LU2111349929.HKD","LU0289739699.SGD","BK4007","ZTS","LU0107464264.USD","LU0158827781.USD","LU1059921491.USD","LU2089284900.SGD","GB00BDT5M118.USD","LU0345774631.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zoetis.com","stockEarnings":[{"period":"1week","weight":0.0457},{"period":"1month","weight":0.1254},{"period":"3month","weight":0.0883},{"period":"6month","weight":-0.2984},{"period":"1year","weight":-0.4426},{"period":"ytd","weight":-0.3483}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0122},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.0701},{"period":"1year","weight":0.144},{"period":"ytd","weight":0.1203}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.014971},{"month":2,"riseRate":0.615385,"avgChangeRate":0.01803},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.019618},{"month":4,"riseRate":0.5,"avgChangeRate":0.012455},{"month":5,"riseRate":0.642857,"avgChangeRate":0.001908},{"month":6,"riseRate":0.642857,"avgChangeRate":0.007202},{"month":7,"riseRate":0.857143,"avgChangeRate":0.035104},{"month":8,"riseRate":0.714286,"avgChangeRate":0.011334},{"month":9,"riseRate":0.5,"avgChangeRate":-0.013756},{"month":10,"riseRate":0.571429,"avgChangeRate":0.004604},{"month":11,"riseRate":0.692308,"avgChangeRate":0.038835},{"month":12,"riseRate":0.538462,"avgChangeRate":0.016303}],"exchange":"NYSE","name":"Zoetis Inc.","nameEN":"Zoetis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zoetis Inc.,ZTS,Zoetis Inc.股票,Zoetis Inc.股票老虎,Zoetis Inc.股票老虎国际,Zoetis Inc.行情,Zoetis Inc.股票行情,Zoetis Inc.股价,Zoetis Inc.股市,Zoetis Inc.股票价格,Zoetis Inc.股票交易,Zoetis Inc.股票购买,Zoetis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}